
Blood Preparation
Description
Global Blood Preparation Market to Reach US$75.4 Billion by 2030
The global market for Blood Preparation estimated at US$53.0 Billion in the year 2024, is expected to reach US$75.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Whole Blood, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$35.2 Billion by the end of the analysis period. Growth in the Blood Derivatives segment is estimated at 6.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$13.7 Billion While China is Forecast to Grow at 9.4% CAGR
The Blood Preparation market in the U.S. is estimated at US$13.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.8 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Global Blood Preparation Market – Key Trends & Drivers Summarized
How is Blood Preparation Evolving in Modern Medicine?
Blood preparation is an essential aspect of modern medical treatment, involving the collection, processing, and storage of blood and its components for use in various therapeutic applications, including transfusions, surgeries, and treatments for blood disorders. The market for blood preparation is evolving rapidly due to advancements in blood component separation, storage technologies, and the development of blood substitutes. Blood preparation includes the processing of whole blood into components such as red blood cells, platelets, plasma, and clotting factors, which are used to treat a range of conditions, from trauma and surgeries to anemia, cancer, and hemophilia.
Technological innovations in blood preparation have significantly improved the safety, efficacy, and shelf life of blood products. For example, pathogen reduction technologies are being developed to improve the safety of blood transfusions by inactivating viruses, bacteria, and parasites in blood components. Furthermore, advancements in storage solutions and cryopreservation techniques are extending the shelf life of blood products, ensuring that they remain viable for longer periods, which is crucial for emergency situations and remote healthcare settings. These innovations are not only improving the availability of blood products but also reducing the risk of transfusion-related complications.
What Role Does Blood Preparation Play in Treating Blood Disorders?
Blood preparation is critical in the treatment of various blood disorders, including anemia, hemophilia, and leukemia. For patients with anemia, red blood cell transfusions are essential for replenishing the body’s oxygen-carrying capacity, especially in cases of severe blood loss, chronic diseases, or chemotherapy. In patients with clotting disorders such as hemophilia, blood preparation involves the extraction and concentration of clotting factors, particularly Factor VIII and Factor IX, which are essential for preventing and controlling bleeding episodes. These concentrated blood products can be administered to patients to restore normal clotting function, significantly improving their quality of life.
In the case of leukemia and other blood cancers, blood preparation is vital for both supportive care and treatment. Patients undergoing chemotherapy or radiation therapy often require platelet transfusions to prevent bleeding and plasma transfusions to manage clotting abnormalities. Additionally, stem cell transplants, which involve the infusion of healthy blood-forming cells, are an important therapeutic option for patients with certain types of blood cancers. The preparation of blood components for stem cell transplants ensures that patients receive the necessary support during their treatment journey, highlighting the importance of advanced blood processing techniques in modern medical care.
How is Blood Preparation Enhancing Surgical and Emergency Care?
In surgical and emergency care, blood preparation plays a pivotal role in saving lives and improving patient outcomes. During major surgeries, especially those involving significant blood loss, prepared blood components such as red blood cells, plasma, and platelets are often required to maintain the patient’s blood volume, support oxygen delivery, and prevent clotting disorders. The ability to quickly access and transfuse these blood products can make the difference between life and death in critical situations. Additionally, blood preparation is essential in trauma care, where rapid transfusions of blood components are necessary to stabilize patients with severe injuries and hemorrhages.
The development of advanced blood preparation techniques, including preoperative autologous blood donation, where patients donate their own blood before surgery, is enhancing patient safety by reducing the need for allogeneic (donor) blood transfusions. This minimizes the risk of transfusion-related complications such as immune reactions or infections. Furthermore, innovations in portable blood storage and preparation devices are improving the ability of emergency medical teams to provide life-saving transfusions in the field, particularly in remote or disaster-stricken areas. These advancements are enhancing the responsiveness and effectiveness of surgical and emergency care, ensuring that patients receive the critical blood products they need when and where they need them.
What Factors Are Driving the Growth of the Blood Preparation Market?
The growth of the blood preparation market is driven by several factors, including the increasing demand for blood products due to rising surgical procedures, trauma cases, and the growing prevalence of blood disorders. The expanding elderly population, which is more susceptible to chronic diseases and surgeries, is contributing to a higher demand for blood products, particularly red blood cells and platelets. In addition, advancements in blood component separation and storage technologies are improving the availability and safety of blood products, encouraging their use in a wider range of medical applications.
Regulatory support and increasing awareness about the importance of blood donation are also driving the market. Government initiatives aimed at improving blood donation infrastructure and ensuring the safety of the blood supply are contributing to the growth of the blood preparation market. The development of blood substitutes, which are designed to mimic the oxygen-carrying capacity of red blood cells, is another area of innovation that is expected to impact the market. While still in the research phase, these substitutes have the potential to address shortages of donated blood and provide alternatives for patients who are unable to receive traditional blood transfusions. Finally, the rising incidence of trauma cases, surgeries, and the growing prevalence of blood-related conditions are fueling the demand for blood preparation products globally.
SCOPE OF STUDY:The report analyzes the Blood Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Product (Whole Blood, Blood Derivatives, Blood Components); Type (Anticoagulants, Platelet Aggregation Inhibitors, Fibrinolytics); Application (Thrombocytosis, Pulmonary Embolism, Angina Blood Vessel Complications, Renal Impairment, Other Applications)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 33 Featured) -
- AstraZeneca plc
- Baxter International Inc
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Leo Pharma A/S
- Pfizer, Inc
- Sanofi
- Xiamen Hisunny Chemical Co., LTD
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Global Economic Update
- Blood Preparation – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Increasing Demand for Blood and Blood Products in Transfusions Propels Growth in the Blood Preparation Market
- Rising Prevalence of Chronic Diseases and Surgeries Expands the Addressable Market for Blood Preparation Products
- Technological Advancements in Blood Storage and Preservation Techniques Drive Innovation in Blood Preparation Solutions
- Growing Focus on Safe Blood Transfusions Strengthens the Business Case for High-Quality Blood Preparation Methods
- Increasing Use of Blood Components in Therapeutic Treatments Expands Market Opportunities for Blood Preparations
- Rising Adoption of Apheresis Technology in Blood Collection Drives Demand for Blood Preparation Solutions
- Growing Focus on Reducing Transfusion-Transmitted Infections (TTIs) Propels Innovation in Safe Blood Preparation Practices
- Increasing Government Initiatives and Blood Donation Programs Fuel Growth in the Blood Preparation Market
- Rising Demand for Plasma-Derived Therapies Expands Opportunities for Blood Preparation in Pharmaceutical Applications
- Technological Advancements in Blood Separation and Filtration Drive Innovation in Blood Component Preparation
- Growing Focus on Reducing Blood Wastage Strengthens Market Demand for Efficient Blood Preparation Techniques
- Increasing Use of Blood Preparation in Cancer Treatments and Chemotherapy Expands Market Applications
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 2: World Historic Review for Blood Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 3: World 15-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 5: World Historic Review for Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 6: World 15-Year Perspective for Whole Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 8: World Historic Review for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 9: World 15-Year Perspective for Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Blood Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 11: World Historic Review for Blood Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 12: World 15-Year Perspective for Blood Derivatives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Renal Impairment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 14: World Historic Review for Renal Impairment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 15: World 15-Year Perspective for Renal Impairment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 18: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Thrombocytosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 20: World Historic Review for Thrombocytosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 21: World 15-Year Perspective for Thrombocytosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 23: World Historic Review for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 24: World 15-Year Perspective for Pulmonary Embolism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 25: World Recent Past, Current & Future Analysis for Angina Blood Vessel Complications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 26: World Historic Review for Angina Blood Vessel Complications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 27: World 15-Year Perspective for Angina Blood Vessel Complications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 28: World Recent Past, Current & Future Analysis for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 29: World Historic Review for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 30: World 15-Year Perspective for Anticoagulants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 31: World Recent Past, Current & Future Analysis for Platelet Aggregation Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 32: World Historic Review for Platelet Aggregation Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 33: World 15-Year Perspective for Platelet Aggregation Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 34: World Recent Past, Current & Future Analysis for Fibrinolytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 35: World Historic Review for Fibrinolytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 36: World 15-Year Perspective for Fibrinolytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 37: World Blood Preparation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 38: USA Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 43: USA 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- CANADA
- TABLE 47: Canada Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 52: Canada 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- JAPAN
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 56: Japan Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 58: Japan 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 59: Japan Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 61: Japan 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- CHINA
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 65: China Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 67: China 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 68: China Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 70: China 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 73: China 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- EUROPE
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 74: Europe Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Blood Preparation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 76: Europe 15-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 82: Europe 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- FRANCE
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 86: France Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 88: France 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 89: France Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 91: France 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 94: France 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- GERMANY
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 95: Germany Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 97: Germany 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 98: Germany Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 100: Germany 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 103: Germany 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- ITALY
- TABLE 104: Italy Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 106: Italy 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 107: Italy Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 109: Italy 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 112: Italy 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 113: UK Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 115: UK 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 116: UK Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 118: UK 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 121: UK 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 122: Spain Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 124: Spain 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 125: Spain Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 127: Spain 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 130: Spain 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 131: Russia Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 133: Russia 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 134: Russia Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 136: Russia 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 139: Russia 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 142: Rest of Europe 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 145: Rest of Europe 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 148: Rest of Europe 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Blood Preparation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 15-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- AUSTRALIA
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 161: Australia Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 163: Australia 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 164: Australia Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 166: Australia 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 169: Australia 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- INDIA
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 170: India Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 172: India 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 173: India Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 175: India 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 178: India 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 181: South Korea 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 184: South Korea 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 187: South Korea 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Blood Preparation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 199: Latin America 15-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 202: Latin America 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 205: Latin America 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 208: Latin America 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 211: Argentina 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 214: Argentina 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 217: Argentina 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 220: Brazil 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 223: Brazil 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 226: Brazil 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 229: Mexico 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 232: Mexico 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 235: Mexico 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Blood Preparation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 247: Middle East 15-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 250: Middle East 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 253: Middle East 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 256: Middle East 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- IRAN
- TABLE 257: Iran Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 259: Iran 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 260: Iran Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 262: Iran 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 265: Iran 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 266: Israel Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 268: Israel 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 269: Israel Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 271: Israel 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 274: Israel 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 284: UAE Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 286: UAE 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 287: UAE Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 289: UAE 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 292: UAE 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- AFRICA
- Blood Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 302: Africa Recent Past, Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Blood Preparation by Product - Whole Blood, Blood Derivatives and Blood Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 304: Africa 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Derivatives and Blood Components for the Years 2015, 2025 & 2030
- TABLE 305: Africa Recent Past, Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 307: Africa 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2015, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
- TABLE 310: Africa 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates